Table 1.
Characteristics of studies included in the meta-analysis.
| No. | Year | Author | Country | Organ | Number | Expression Cancer (+/−) Control (+/−) |
Age Old (+/−) Young (+/−) |
TNM 3,4 (+/−) 1,2 (+/−) |
Differentiation Low (+/−) High (+/−) |
Lymph node metastasis Metastasis (+/−) Non-metastasis (+/−) |
Overall survival time (month) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2013 | Gao SS [5] | China | Cervical | 84 | 36/6 15/27 |
NA | NA | NA | NA | NA |
| 2 | 2012 | Lu JH [12] | China | Cervical | 101 | 27/3 37/34 |
NA | NA | NA | NA | NA |
| 3 | 2011 | Cao YX [13] | China | Cervical | 93 | 42/15 10/26 |
14/3 21/2 |
28/11 8/12 |
15/2 22/18 |
10/0 11/8 |
(+) 66.10±2.78 (−) 77.79±2.22 |
| 4 | 2013 | Wang ZR [14] | China | Cervical | 75 | 29/11 10/25 |
20/24 9/7 |
15/1 14/10 |
12/0 17/11 |
9/1 7/11 |
NA |
| 5 | 2008 | Joseph P [15] | America | Ovarian | 44 | 4/0 18/22 |
NA | NA | 21/19 1/3 |
NA | Median: (+) 31 (−) 36 |
| 6 | 2015 | Cheng L [6] | China | Ovarian | 153 | 77/9 15/52 |
49/3 28/6 |
56/2 21/7 |
52/2 25/7 |
48/2 29/7 |
Median: (+) 31 (−) 46 |
| 7 | 2009 | Wang JO [16] | China | Ovarian | 106 | 44/27 7/28 |
6/3 35/14 |
21/3 20/14 |
21/4 20/13 |
NA | NA |
| 8 | 2011 | Gao HH [17] | China | Breast | 82 | 24/17 10/31 |
NA | 7/1 17/16 |
NA | 17/4 7/13 |
NA |
| 9 | 2005 | Wang LP [7] | China | Breast | 53 | 18/11 0/4 |
NA | NA | NA | 14/6 4/5 |
NA |
| 10 | 2007 | Shan GP [18] | China | Breast | 74 | 25/16 0/33 |
11/8 13/8 |
6/2 19/14 |
11/5 14/11 |
20/7 5/9 |
NA |
| 11 | 2010 | Chen G [19] | China | Breast | 136 | 58/21 0/57 |
32/13 26/8 |
51/6 7/15 |
29/1 29/20 |
32/1 26/20 |
NA |
| 12 | 2014 | Wu QW [20] | China | Breast | 126 | 58/5 34/29 |
17/1 41/4 |
5/1 53/4 |
30/2 23/3 |
28/2 30/3 |
NA |